Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and moderate to severe renal impairment: an integrated analysis [abstract 0715B] | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and moderate to severe renal impairment: an integrated analysis [abstract 0715B]

Lawitz EJ, Gane EJ, Zadeikis N, et al. Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and moderate to severe renal impairment: an integrated analysis [abstract 0715B]. The Liver Meeting. San Francisco, CA; 2018.

Publication Type:

Conference Proceedings

Authors:

Lawitz, EJ; Gane, EJ; Zadeikis, N; et, al

Source:

The Liver Meeting, San Francisco, CA (2018)

Cited On:

Patients with Renal Impairment

Export Citation:

RIS Format

Top